Literature DB >> 7640590

Transverse myelitis after measles, mumps, and rubella vaccine.

K A Joyce1, J E Rees.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7640590      PMCID: PMC2550491          DOI: 10.1136/bmj.311.7002.422a

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  2 in total

1.  Diffuse myelitis associated with rubella vaccination.

Authors:  S Holt; D Hudgins; K R Krishnan; E M Critchley
Journal:  Br Med J       Date:  1976-10-30

Review 2.  Neurological complications of immunization.

Authors:  G M Fenichel
Journal:  Ann Neurol       Date:  1982-08       Impact factor: 10.422

  2 in total
  6 in total

1.  Transverse myelitis unlikely to be due to measles, mumps, and rubella vaccine.

Authors:  R Fescharek; H Dass
Journal:  BMJ       Date:  1995-12-16

Review 2.  Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?

Authors:  Shani Witman Tsur; Eli Adrian Zaher; Meydan Tsur; Karolina Kania; Alicja Kalinowska-Łyszczarz
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

3.  Safety of Second-Dose Single-Antigen Varicella Vaccine.

Authors:  John R Su; Zanie Leroy; Paige W Lewis; Penina Haber; Mona Marin; Jessica Leung; Emily Jane Woo; Tom T Shimabukuro
Journal:  Pediatrics       Date:  2017-02-07       Impact factor: 7.124

Review 4.  Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature.

Authors:  Erum Khan; Ashish K Shrestha; Mark A Colantonio; Richard N Liberio; Shitiz Sriwastava
Journal:  J Neurol       Date:  2021-09-05       Impact factor: 6.682

5.  The "urban myth" of the association between neurological disorders and vaccinations.

Authors:  R Gasparini; D Panatto; P L Lai; D Amicizia
Journal:  J Prev Med Hyg       Date:  2015-06-10

Review 6.  Vaccination in Multiple Sclerosis: Friend or Foe?

Authors:  Tobias Zrzavy; Herwig Kollaritsch; Paulus S Rommer; Nina Boxberger; Micha Loebermann; Isabella Wimmer; Alexander Winkelmann; Uwe K Zettl
Journal:  Front Immunol       Date:  2019-08-07       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.